Related Experiment Videos

[Neonatal hypoglycemia--new limits for treatment?]

O A Pryds1, S Petersen

  • 1Neonatalklinikken, Rigshospitalet, København.

Ugeskrift for Laeger
|August 14, 1995
PubMed

Insights

Neonatal hypoglycemia, a common sign of metabolic issues, can harm brain development. Maintaining blood glucose above 2.5 mM with early feeding or IV glucose is crucial for high-risk infants.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Metabolic Disorders

Context:

  • Neonatal hypoglycemia is a frequent clinical sign of disturbed energy metabolism.
  • Sustained low blood glucose levels in newborns can lead to irreversible neuronal damage.
  • Identifying infants at high risk is critical for timely intervention.

Purpose:

  • To highlight the importance of neonatal hypoglycemia and its potential consequences.
  • To define risk factors associated with developing low brain energy levels in infants.
  • To provide evidence-based recommendations for blood glucose management in at-risk neonates.

Summary:

  • Neonatal hypoglycemia is the most common clinical manifestation of disordered energy metabolism.
  • Infants at high risk have increased metabolic demands, low glycogen reserves, insufficient counter-regulatory responses, or hyperinsulinemia.
  • Maintaining blood glucose above 2.5 mM is recommended, with early feeding (120 ml/kg/day) and potential intravenous glucose supplementation.

Impact:

  • Informs clinical practice regarding the management of neonatal hypoglycemia.
  • Emphasizes the need for vigilant monitoring of blood glucose in at-risk infants.
  • Contributes to preventing long-term neurological deficits in newborns.

Related Concept Videos